Rankings
▼
Calendar
XOMAP Q4 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
+375.4% YoY
Gross Profit
$9M
97.7% margin
Operating Income
-$16M
-186.5% margin
Net Income
-$4M
-45.5% margin
EPS (Diluted)
$0.82
QoQ Revenue Growth
+21.1%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$221M
Total Liabilities
$139M
Stockholders' Equity
$82M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$2M
+375.4%
Gross Profit
$9M
$2M
+370.9%
Operating Income
-$16M
-$20M
+18.5%
Net Income
-$4M
-$20M
+80.3%
← FY 2024
All Quarters
Q1 2025 →